3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546
Clinical trial NCT04727138 · COMPLETED
Trial details
- NCT number
- NCT04727138
- Sponsor
- Exscientia AI Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2022-04-16
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.